Published in Proteomics Weekly, November 15th, 2004
Genetically engineered, or biologic, tumor necrosis factor (TNF) inhibitors suppress the TNF proteins that cause joint inflammation, a beneficial therapy in the day-to-day lives of many arthritis patients. However, because the same TNF protein also plays a key role in suppressing infections with certain bacteria in the body, continued use of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly